Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01695213
Other study ID # Symax DEXA study
Secondary ID MEC 02-072
Status Completed
Phase Phase 4
First received September 25, 2012
Last updated September 25, 2012
Start date April 2003
Est. completion date July 2009

Study information

Verified date September 2012
Source Maastricht University Medical Center
Contact n/a
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Interventional

Clinical Trial Summary

Thr purpose of this study is to compare the clinical and radiological results, as well as the femur bone density measurements of two uncemented total hip prostheses during 5 years of follow up.


Description:

It is of great importance for the function of uncemented total hip arthroplasty that the anchorage of the prosthesis in the bone of the femur is sufficient. This is of great importance in the prevention of stress shielding of the bone and to insure tranfer of forces from the prosthesis to the femur.

The symax hip stem is developed to optimize stress tranfer to bone and insure mechanical stability.

In this study the symax hip stem is compared to the HA_Omnifit hip stem (a frequently used and long term evaluated uncemented hip prosthesis) During the fist two years of follow up DEXA mesurments of bone mineral density are performed. Also patient satisfaction, patient fuction score and radiological evaluation measurements are done during 5 years of follow up.

Our primary objective is: comparison of the short term bone remodelling surrounding the Symax hip stem to the short term remodeling surrounding the Stryker Omnifit HA hip stem measured by bone densitometry, clinical and radiographic evaluation.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date July 2009
Est. primary completion date July 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:Male or non pregnant female patients >18 years

- Patient with degenerative or traumatic changes to hip requiring hip replacement

- Patient with BMI<35

- Patient signed informed consent

Exclusion Criteria:

- chronic anti-inflammatory medication use> 3 months

- revision surgery to the affected femur

- Cancer therapy including immunosuppression, chemotherapy and radiation

- Pathological fractures, delayed ossification or non-union is likely to occur

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Osteoarthritis, Hip
  • Patients With Osteoarthritis of the Hip Joint Elligable for a Uncemented Hipprosthesis

Intervention

Procedure:
uncemented total hip arthroplasty


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Maastricht University Medical Center Stryker European Operations BV

Outcome

Type Measure Description Time frame Safety issue
Other patient satisfaction comparison of patient satisfaction between the two different prostheses 9 times within 5 years No
Primary short term bone remodeling Bone remodeling is determined by measuring the Bone mineral density during time 6 times within 2 years No
Primary complications and reoperations Reporting all complications and reoperations of the two different hip prostheses during 5 years Yes
Secondary clinical performance Comparison of the clinical performance of the two different hip prostheses 9 times within 5 years No
Secondary Radiological evaluation Evaluation of Xrays according to the engh classifications 9 times within 5 years No